Kim Lorence H.: insider trades.
Kim Lorence H. reported 14 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 14 sales ($15.0M), across 1 company.
- Transactions
- 14
- Purchases (P)
- 0
- Sales (S)
- 14
- Companies
- 1
- Name as filed
- Kim Lorence H.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Revolution Medicines, Inc. (RVMD) | Director | 14 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-08 | Revolution Medicines, Inc. | S | 706 | $206.6 | 16,384 | Form 4 |
| 2026-09-08 | Revolution Medicines, Inc. | S | 999 | $207.33 | 15,385 | Form 4 |
| 2026-09-08 | Revolution Medicines, Inc. | S | 3,587 | $208.55 | 11,798 | Form 4 |
| 2026-09-08 | Revolution Medicines, Inc. | S | 371 | $212.27 | 0 | Form 4 |
| 2026-09-08 | Revolution Medicines, Inc. | S | 4,730 | $210.5 | 4,215 | Form 4 |
| 2026-09-08 | Revolution Medicines, Inc. | S | 3,844 | $211.36 | 371 | Form 4 |
| 2026-09-08 | Revolution Medicines, Inc. | S | 2,853 | $209.56 | 8,945 | Form 4 |
| 2026-08-31 | Revolution Medicines, Inc. | S | 625 | $206.15 | 17,090 | Form 4 |
| 2026-08-31 | Revolution Medicines, Inc. | S | 300 | $200.56 | 72,790 | Form 4 |
| 2026-08-31 | Revolution Medicines, Inc. | S | 6,597 | $201.47 | 66,193 | Form 4 |
| 2026-08-31 | Revolution Medicines, Inc. | S | 26,160 | $203.55 | 27,114 | Form 4 |
| 2026-08-31 | Revolution Medicines, Inc. | S | 7,271 | $204.35 | 19,843 | Form 4 |
| 2026-08-31 | Revolution Medicines, Inc. | S | 12,919 | $202.48 | 53,274 | Form 4 |
| 2026-08-31 | Revolution Medicines, Inc. | S | 2,128 | $205.19 | 17,715 | Form 4 |
Questions
What stock did Kim Lorence H. buy or sell?
Kim Lorence H. reported 14 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 14 sales ($15.0M), across 1 company.
Is Kim Lorence H. the same person as other filers with this name?
This page covers SEC CIK 1643746 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/kim-lorence-h-1643746.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.